| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 12/06/2024 | 22:30 | Business Wire | Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy | NYSE:PFE | Pfizer Inc |
| 11/06/2024 | 20:43 | Edgar (US Regulatory) | Form 11-K - Annual report of employee stock purchase, savings and similar plans | NYSE:PFE | Pfizer Inc |
| 10/06/2024 | 13:29 | IH Market News | Apple Showcases AI at WWDC 2024, Nvidia Stock Split Starts Today, and More News | NYSE:PFE | Pfizer Inc |
| 05/06/2024 | 22:05 | GlobeNewswire Inc. | Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 | NYSE:PFE | Pfizer Inc |
| 04/06/2024 | 23:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:PFE | Pfizer Inc |
| 03/06/2024 | 16:00 | Business Wire | Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference | NYSE:PFE | Pfizer Inc |
| 01/06/2024 | 14:00 | Business Wire | Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma | NYSE:PFE | Pfizer Inc |
| 01/06/2024 | 14:00 | Business Wire | Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) | NYSE:PFE | Pfizer Inc |
| 31/05/2024 | 18:15 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NYSE:PFE | Pfizer Inc |
| 31/05/2024 | 14:00 | Business Wire | Pfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease Progression | NYSE:PFE | Pfizer Inc |
| 23/05/2024 | 13:40 | IH Market News | OpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More News | NYSE:PFE | Pfizer Inc |
| 22/05/2024 | 18:39 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:PFE | Pfizer Inc |
| 16/05/2024 | 13:27 | IH Market News | Chubb Stock Soars 9% with Berkshire Acquisition, AST SpaceMobile jumps 37% on AT&T deal, and More News | NYSE:PFE | Pfizer Inc |
| 16/05/2024 | 12:00 | GlobeNewswire Inc. | Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) | NYSE:PFE | Pfizer Inc |
| 13/05/2024 | 14:00 | PR Newswire (US) | Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting | NYSE:PFE | Pfizer Inc |
| 13/05/2024 | 13:16 | IH Market News | Arm Sets 2025 Target for AI Chip Development, Amazon and Microsoft Commit Billions to French Investments, and More | NYSE:PFE | Pfizer Inc |
| 09/05/2024 | 15:01 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:PFE | Pfizer Inc |
| 09/05/2024 | 13:53 | IH Market News | Bain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More News | NYSE:PFE | Pfizer Inc |
| 08/05/2024 | 21:56 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:PFE | Pfizer Inc |
| 06/05/2024 | 12:45 | Business Wire | Pfizer Announces New Chief Strategy and Innovation Officer | NYSE:PFE | Pfizer Inc |
| 01/05/2024 | 15:12 | IH Market News | CVS Health, Starbucks, Shares Weaker; Pinterest Soars | NYSE:PFE | Pfizer Inc |
| 01/05/2024 | 12:45 | Business Wire | Pfizer Reports First-Quarter 2024 Results | NYSE:PFE | Pfizer Inc |
| 30/04/2024 | 00:40 | Business Wire | FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer | NYSE:PFE | Pfizer Inc |
| 30/04/2024 | 00:40 | Business Wire | TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer | NYSE:PFE | Pfizer Inc |
| 29/04/2024 | 12:45 | Business Wire | Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting | NYSE:PFE | Pfizer Inc |
| 26/04/2024 | 13:48 | IH Market News | Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News | NYSE:PFE | Pfizer Inc |
| 26/04/2024 | 12:45 | Business Wire | U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B | NYSE:PFE | Pfizer Inc |
| 24/04/2024 | 22:37 | Business Wire | Pfizer Declares Second-Quarter 2024 Dividend | NYSE:PFE | Pfizer Inc |
| 24/04/2024 | 13:28 | IH Market News | Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News | NYSE:PFE | Pfizer Inc |
| 22/04/2024 | 14:08 | Business Wire | European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options | NYSE:PFE | Pfizer Inc |